|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Jun―02 |
Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort |
Chung-Feng Huang, Tyng-Yuan Jang, Ping-Hsun Wu, Mei-Chuan Kuo, Ming-Lun Yeh, Chih-Wen Wang, et al. (+19) Po-Cheng Liang, Yu-Ju Wei, Po-Yao Hsu, Ching-I Huang, Ming-Yen Hsieh, Yi-Hung Lin, Hui-Hua Hsiao, Chin-Mu Hsu, Chien-Tzu Huang, Chun-Yuan Lee, Yen-Hsu Chen, Tun-Chieh Chen, Kun-Der Lin, Shuo-Hung Wang, Sheng-Fan Wang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu |
2 |
[GO] |
2023―Jun―01 |
Causal associations between chronic hepatitis B and COVID-19 in East Asian populations |
Zhenguo Liu, Linnan Song, Junling Chen, Yongjun Zhou, Yuhao Wang, Libo Tang, Yongyin Li |
3 |
[GO] |
2023―May―29 |
Clinical characteristics and host immunity responses of SARS-CoV-2 Omicron variant BA.2 with deletion of ORF7a, ORF7b and ORF8 |
Zhizhong Tang, Pei Yu, Qianfang Guo, Mingxiao Chen, Yu Lei, Lei Zhou, et al. (+12) Weikang Mai, Lu Chen, Min Deng, Weiya Kong, Chuanying Niu, Xiaoli Xiong, Wenrui Li, Chunbo Chen, Changchun Lai, Qian Wang, Baisheng Li, Tianxing Ji |
4 |
[GO] |
2023―May―19 |
Ultrastructural study confirms the formation of single and heterotypic syncytial cells in bronchoalveolar fluids of COVID-19 patients |
Shikha Chaudhary, Ravi P. Yadav, Shailendra Kumar, Subhash Chandra Yadav |
5 |
[GO] |
2023―May―15 |
Evaluation of circulating insulin-like growth factor-1, heart-type fatty acid-binding protein, and endotrophin levels as prognostic markers of COVID-19 infection severity |
Amal A. Mohamed, Aya A. Nour, Noha M. Mosbah, Alaa S. M. Wahba, Omnia E. Esmail, Basem Eysa, et al. (+9) Ahmed Heiba, Hussin H. Samir, Ahmed A. El-Kassas, Ahmed S. Adroase, Ahmed Y. Elamir, Ghada M. Mahmoud, Rasha S. Rafaat, Hatem A. Hassan, Yasmine S. El Abd |
6 |
[GO] |
2023―May―08 |
Predictive values of procalcitonin for coinfections in patients with COVID-19: a systematic review and meta-analysis |
Shanchen Wei, Lina Wang, Lianjun Lin, Xinmin Liu |
7 |
[GO] |
2023―May―05 |
Systematic levels of IL-29 and microRNA185-5p were not associated with severe COVID-19 in the Iranian population |
Omidreza Sarrafi, Ashraf Kariminik, Mohammad Kazemi Arababadi |
8 |
[GO] |
2023―May―03 |
Differential abundance of IgG antibodies against the spike protein of SARS-CoV-2 and seasonal coronaviruses in patients with fatal COVID-19 |
Wouter L. Smit, Sophie van Tol, Lenneke E. M. Haas, Gijs J. M. Limonard, Ailko Bossink, Chantal Reusken, et al. (+2) Michiel Heron, Steven F. T. Thijsen |
9 |
[GO] |
2023―May―02 |
Water bath is more efficient than hot air oven at thermal inactivation of coronavirus |
Xinxia Gu, Ting Cao, Jun Mou, Jie Liu |
10 |
[GO] |
2023―Apr―26 |
Evaluating anti-viral effect of Tylvalosin tartrate on porcine reproductive and respiratory syndrome virus and analyzing the related gene regulation by transcriptomics |
Xingzhen Tang, Cong Wang, Weifeng Sun, Weixin Wu, Shaohui Sun, Jin Wan, et al. (+7) Guangshan Zhu, Nini Ma, Xiaoping Ma, Ruihua Xu, Qiushi Yang, Yindi Dai, Lei Zhou |
11 |
[GO] |
2023―Apr―20 |
MHC class I links with severe pathogenicity in C57BL/6N mice infected with SARS-CoV-2/BMA8 |
Tian Qin, Beilei Shen, Entao Li, Song Jin, Rongbo Luo, Yiming Zhang, et al. (+6) Jing Qi, Xiuwen Deng, Zhuangzhuang Shi, Tiecheng Wang, Yifa Zhou, Yuwei Gao |
12 |
[GO] |
2023―Apr―18 |
Comparison of 14 respiratory pathogens among hospitalized children during and after the COVID-19 outbreak in Chaoshan area |
Chuang-Xing Lin, Hao-bin Lian, Guang-Yu Lin, Dan-gui Zhang, Xiao-Ying Cai, Fei-qiu Wen |
13 |
[GO] |
2023―Apr―11 |
SARS-CoV-2 infection aggravates cigarette smoke-exposed cell damage in primary human airway epithelia |
Rui Chen, Kenrie Pui-Yan Hui, Yingmin Liang, Ka-Chun Ng, John Malcolm Nicholls, Mary Sau-Man Ip, et al. (+3) Malik Peiris, Michael Chi-Wai Chan, Judith Choi-Wo Mak |
14 |
[GO] |
2023―Apr―07 |
An optimized circular polymerase extension reaction-based method for functional analysis of SARS-CoV-2 |
GuanQun Liu, Michaela U. Gack |
15 |
[GO] |
2023―Apr―03 |
A comparison of transmissibility of SARS-CoV-2 variants of concern |
S. S. Manathunga, I. A. Abeyagunawardena, S. D. Dharmaratne |
16 |
[GO] |
2023―Mar―30 |
Evaluation of ten (10) SARS-CoV-2 rapid serological tests in comparison with WANTAI SARS-CoV-2 ab ELISA in Burkina Faso, West Africa |
Henri Gautier Ouedraogo, Abdou Azaque Zoure, Tegwinde Rebeca Compaoré, Herve Ky, Sylvie Zida, Dezemon Zingué, et al. (+15) Oumarou Ouedraogo, Serge Théophile Soubeiga, Tani Sagna, Charlemagne Dabiré, Dinanibè Kambiré, Dramane Zongo, Albert Théophane Yonli, Abdoul Rahamani Nikiema, Désiré Nezien, Gnintassa Cyrille Bansé, Brice Wilfried Bicaba, Sophie Perier, Charles Sawadogo, Zakariya Yabre, Lassana Sangare |
17 |
[GO] |
2023―Mar―30 |
SARS-CoV2 mutations and impact on mortality: observational study in a sub-saharan Africa hospital |
Jean-Robert Makulo, Roger Wumba, Madone Ndona Mandina, Placide Mbala, Adrienne Amuri Aziza, Yannick Mayamba Nlandu, et al. (+11) Benjanmin Kabwe, Donatien Mangala, Ben Izizag Bepouka, Jerome Ossam Odio, Murielle Longokolo, Eric Mukenge, Guyguy Kamwiziku, Eddy Lusamaki Kingand, Constantin Bashengezi, Gilbert Kabanda, Benjamin Longo-Mbenza |
18 |
[GO] |
2023―Mar―30 |
SARS-CoV-2 viral protein Nsp2 stimulates translation under normal and hypoxic conditions |
Nadejda Korneeva, Md Imtiaz Khalil, Ishita Ghosh, Ruping Fan, Thomas Arnold, Arrigo De Benedetti |
19 |
[GO] |
2023―Mar―27 |
Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies |
Katerina Jazbec, Mojca Jež, Klemen Žiberna, Polonca Mali, Živa Ramšak, Urška Rahne Potokar, et al. (+7) Zdravko Kvrzić, Maja Černilec, Melita Gracar, Marjana Šprohar, Petra Jovanovič, Sonja Vuletić, Primož Rožman |
20 |
[GO] |
2023―Mar―05 |
A full genome tiling array enhanced the inspection and quarantine of SARS-CoV-2 |
Runzi Qi, Gang Wang, Xu Wang, Cheng Li, Lei Huang, Weixi Xiao, et al. (+5) Bing Shao, Chunya Zhou, Xun Ding, Feng Li, Wei Zhou |
21 |
[GO] |
2023―Mar―01 |
Oligonucleotide usage in coronavirus genomes mimics that in exon regions in host genomes |
Yuki Iwasaki, Takashi Abe, Toshimichi Ikemura |
22 |
[GO] |
2023―Feb―25 |
Insights into organoid-based modeling of COVID-19 pathology |
Mohadese Hashem Boroojerdi, Tariq Al Jabry, Seyed Mohamad Javad Mirarefin, Halima Albalushi |
23 |
[GO] |
2023―Feb―25 |
Intragenomic rearrangements involving 5′-untranslated region segments in SARS-CoV-2, other betacoronaviruses, and alphacoronaviruses |
Roberto Patarca, William A. Haseltine |
24 |
[GO] |
2023―Feb―24 |
Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol |
Sharonjit K. Dhillon, Cindy Simoens, Lize Cuypers, Jannes Bode, Jesper Bonde, Philippe Corbisier, et al. (+3) Clementina E. Cocuzza, Marc Van Ranst, Marc Arbyn |
25 |
[GO] |
2023―Feb―21 |
The detectable anti-interferon-γ autoantibodies in COVID-19 patients may be associated with disease severity |
Po-Ku Chen, Kai-Jieh Yeo, Shih-Hsin Chang, Tsai-Ling Liao, Chia-Hui Chou, Joung-Liang Lan, et al. (+2) Ching-Kun Chang, Der-Yuan Chen |
26 |
[GO] |
2023―Feb―17 |
Analysis of 3.5 million SARS-CoV-2 sequences reveals unique mutational trends with consistent nucleotide and codon frequencies |
Sarah E. Fumagalli, Nigam H. Padhiar, Douglas Meyer, Upendra Katneni, Haim Bar, Michael DiCuccio, et al. (+2) Anton A. Komar, Chava Kimchi-Sarfaty |
27 |
[GO] |
2023―Feb―11 |
SARS-CoV-2 BA.2 (Omicron) variant infection in pediatric liver transplanted recipients and cohabitants during 2022 Shanghai outbreak: a prospective cohort |
Xin-ye Zhu, Ye-feng Lu, Feng Xue, Yi Luo, Ming-xuan Feng, Bi-jun Qiu, et al. (+5) Tao Zhou, Jian-jun Zhu, Jian-jun Zhang, Ping Wan, Qiang Xia |
28 |
[GO] |
2023―Feb―08 |
An overview on the treatments and prevention against COVID-19 |
Yunes Panahi, Armita Mahdavi Gorabi, Sona Talaei, Fatemeh Beiraghdar, Abolfazl Akbarzadeh, Vahideh Tarhriz, Hassan Mellatyar |
29 |
[GO] |
2023―Feb―07 |
Impaired antibody responses were observed in patients with type 2 diabetes mellitus after receiving the inactivated COVID-19 vaccines |
Feng Xiang, Boyu Long, Jiaoxia He, Feifei Cheng, Sijing Zhang, Qing Liu, et al. (+7) Zhiwei Chen, Hu Li, Min Chen, Mingli Peng, Wenwei Yin, Dongfang Liu, Hong Ren |
30 |
[GO] |
2023―Feb―06 |
Visualization of SARS-CoV-2 particles in naso/oropharyngeal swabs by thin section electron microscopy |
Michael Laue, Tobias Hoffmann, Janine Michel, Andreas Nitsche |
31 |
[GO] |
2023―Jan―31 |
Bafilomycin A1 inhibits SARS-CoV-2 infection in a human lung xenograft mouse model |
Cuiling Zhang, Bingjie Wei, Zirui Liu, Wei Yao, Yiquan Li, Jing Lu, et al. (+7) Chenchen Ge, Xiaoyang Yu, Dapeng Li, Yilong Zhu, Chao Shang, Ningyi Jin, Xiao Li |
32 |
[GO] |
2023―Jan―25 |
High titers of neutralizing SARS-CoV-2 antibodies six months after symptom onset are associated with increased severity in COVID-19 hospitalized patients |
Adin Sejdic, Anders Frische, Charlotte Sværke Jørgensen, Lasse Dam Rasmussen, Ramona Trebbien, Arnold Dungu, et al. (+9) Jon G. Holler, Sisse Rye Ostrowski, Robert Eriksson, Christian Søborg, Thyge L. Nielsen, Thea K. Fischer, Birgitte Lindegaard, Kristina Træholt Franck, Zitta Barrella Harboe |
33 |
[GO] |
2023―Jan―10 |
The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics |
Wenbing Wu, Ying Cheng, Hong Zhou, Changzhen Sun, Shujun Zhang |
34 |
[GO] |
2023―Jan―09 |
The changed endemic pattern of human adenovirus from species B to C among pediatric patients under the pressure of non-pharmaceutical interventions against COVID-19 in Beijing, China |
Fangming Wang, Runan Zhu, Yuan Qian, Yu Sun, Dongmei Chen, Fang Wang, et al. (+7) Yutong Zhou, Qi Guo, Liying Liu, Yanpeng Xu, Ling Cao, Dong Qu, Linqing Zhao |
35 |
[GO] |
2023―Jan―07 |
Trajectory of confirmed cases and deaths: fourth wave of COVID-19 epidemic in Myanmar |
Ye Minn Htun, Thinzar Aung, Myo Su Kyi, Nyan Htet Shan, Zin Thu Winn, Kaung Si Thu, et al. (+3) Nyan Lin Maung, Tun Tun Win, Kyaw Myo Tun |
36 |
[GO] |
2023―Jan―07 |
A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases |
Zahra Hamidi, Shaghaiegh Jabraeili-Siahroud, Yalda Taati-Alamdari, Parisa Shiri Aghbash, Ali Shamekh, Hossein Bannazadeh Baghi |
37 |
[GO] |
2022―Dec―30 |
Highly efficacious and safe neutralizing DNA aptamer of SARS-CoV-2 as an emerging therapy for COVID-19 disease |
Mohamad Ammar Ayass, Trivendra Tripathi, Natalya Griko, Victor Pashkov, Jun Dai, Jin Zhang, et al. (+6) Fabian C. Herbert, Ramya Ramankutty Nair, Tutku Okyay, Kevin Zhu, Jeremiah J. Gassensmith, Lina Abi-Mosleh |
38 |
[GO] |
2022―Dec―22 |
Adaptive immune responses and cytokine immune profiles in humans following prime and boost vaccination with the SARS-CoV-2 CoronaVac vaccine |
Chan Wang, Songhao Yang, Liangwei Duan, Xiancai Du, Jia Tao, Yana Wang, et al. (+10) Jihui Yang, Yongxue Lv, Junliang Li, Cuiying Zhang, Jia Wen, Yazhou Zhu, Liangliang Chang, Hui Wang, Qi Wang, Wei Zhao |
39 |
[GO] |
2022―Dec―18 |
Mutations in SARS-CoV-2 structural proteins: a global analysis |
Mohammad Abavisani, Karim Rahimian, Bahar Mahdavi, Samaneh Tokhanbigli, Mahsa Mollapour Siasakht, Amin Farhadi, et al. (+3) Mansoor Kodori, Mohammadamin Mahmanzar, Zahra Meshkat |
40 |
[GO] |
2022―Dec―15 |
The challenges and opportunities of scRNA-seq in COVID-19 research and clinical translation |
Wendao Liu, Xiaohua Ye, Zhiqiang An, Zhongming Zhao |
41 |
[GO] |
2022―Dec―15 |
Neutralizing monoclonal antibody in patients with coronavirus disease 2019: an observational study |
Xuejiao Liao, Dapeng Li, Jie Liu, Zhi Liu, Zhenghua Ma, Jingke Dong, et al. (+5) Xiangyi Yang, Dan Shu, Jing Yuan, Lei Liu, Zheng Zhang |
42 |
[GO] |
2022―Dec―12 |
Recent increase in the detection of human parainfluenza virus during the coronavirus disease-2019 pandemic in the Republic of Korea |
Heui Man Kim, Jee Eun Rhee, Nam-Joo Lee, Sang Hee Woo, Ae Kyung Park, Jaehee Lee, et al. (+2) Cheon Kwon Yoo, Eun-Jin Kim |
43 |
[GO] |
2022―Dec―10 |
Development of novel monoclonal antibodies against nsp12 of SARS-CoV-2 |
Mitsuhiro Machitani, Junko Takei, Mika K. Kaneko, Saori Ueki, Hirofumi Ohashi, Koichi Watashi, et al. (+2) Yukinari Kato, Kenkichi Masutomi |
44 |
[GO] |
2022―Dec―09 |
Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants |
Guochao Liao, Hungyan Lau, Zhongqiu Liu, Chinyu Li, Zeping Xu, Xiaoxiao Qi, et al. (+29) Yu Zhang, Qian Feng, Runze Li, Xinyu Deng, Yebo Li, Qing Zhu, Sisi Zhu, Hua Zhou, Hudan Pan, Xingxing Fan, Yongchao Li, Dan Li, Liqing Chen, Bixia Ke, Zhe Cong, Qi Lv, Jiangning Liu, Dan Liang, An’an Li, Wenshan Hong, Linlin Bao, Feng Zhou, Hongbin Gao, Shi Liang, Bihong Huang, Miaoli Wu, Chuan Qin, Changwen Ke, Liang Liu |
45 |
[GO] |
2022―Dec―08 |
Discovery of vaccine-like recombinant SARS-CoV-2 circulating in human |
Daniel Chang He, Cheng-Qiang He |
46 |
[GO] |
2022―Dec―03 |
Therapeutic and diagnostic applications of nanoparticles in the management of COVID-19: a comprehensive overview |
Omid Gholizadeh, Saman Yasamineh, Parya Amini, Hamed Afkhami, Abbasali Delarampour, Sama Akbarzadeh, et al. (+5) Rasool Karimi Matloub, Mahlagha Zahedi, Parastoo Hosseini, Mehrnaz Hajiesmaeili, Vahdat Poortahmasebi |
47 |
[GO] |
2022―Nov―28 |
Transcriptional differences between coronavirus disease 2019 and bacterial sepsis |
Hiroshi Ito, Masakazu Ishikawa, Hisatake Matsumoto, Fuminori Sugihara, Daisuke Okuzaki, Haruhiko Hirata, Hiroshi Ogura |
48 |
[GO] |
2022―Nov―25 |
Assessment of antibody responses against SARS-CoV-2 in unvaccinated individuals and vaccinees from Omicron-BA.2 infection in Zhaoqing, Guangdong Province, China |
Huan Zhang, Yushan Jiang, Hanqing Tan, Lirong Zou, Zhonghua Zheng, Yushi Huang, et al. (+8) Shujian Lin, Lebin Su, Jianxiang Yu, Xiaoling Deng, Jianfeng He, Chang Liu, Chenguang Shen, Baisheng Li |
49 |
[GO] |
2022―Nov―22 |
SARS-CoV-2 accessory protein 7b forms homotetramers in detergent |
Wahyu Surya, Maria Queralt-Martin, Yuguang Mu, Vicente M. Aguilella, Jaume Torres |
50 |
[GO] |
2022―Nov―19 |
Characteristics of lymphocyte subset alterations in COVID-19 patients with different levels of disease severity |
Wei Dai, Aifang Zhong, Qinghua Qiao, Jian Wu, Weiwei Li, Qiuyue Wu, et al. (+5) Hongjian Zhou, Shijie Qin, Weijun Jiang, Jing Zhang, Xinyi Xia |
51 |
[GO] |
2022―Nov―18 |
Comparison of the performance of two real-time fluorescent quantitative PCR kits for the detection of SARS-CoV-2 nucleic acid: a study based on large real clinical samples |
Yiting Wang, Xuewen Li, Yifei Wang, Zheyu Tu, Jiancheng Xu, Junqi Pan, Qi Zhou |
52 |
[GO] |
2022―Nov―17 |
Re-evaluating our language when reducing risk of SARS-CoV-2 transmission to healthcare workers: Time to rethink the term, “aerosol-generating procedures” |
Andrew Silvers, David J. Brewster, Alister Ford, Ana Licina, Cassandra Andrews, Mark Adams |
53 |
[GO] |
2022―Nov―13 |
IgG response to spike protein of SARS-CoV-2 in healthy individuals and potential of intravenous IgG as treatment for COVID-19 |
Gang Wang, Zebao He, Fengtian Wu, Zhengming Ge, Jiansheng Zhu, Zhi Chen |
54 |
[GO] |
2022―Nov―08 |
Whole-genome sequence analysis reveals the circulation of multiple SARS-CoV-2 variants of concern in Nairobi and neighboring counties, Kenya between March and July 2021 |
Samoel Ashimosi Khamadi, Silvanos Opanda, Samwel Lifumo Symekher, Samson Konongoi Limbaso, Solomon Langat, Josyline Kaburi Cirindi, et al. (+15) Milkah Mwangi, Nicholas Mwikwabe, Seth Okeyo, Edith Koskei, James Mutisya, Samwel Owaka, Albert Nyunja, Hellen Koka, Meshack Wadegu, Esther Chitechi, Rachel Achilla, Janet Masitsa Majanja, Lucy Kanyara, Evans Amukoye, Wallace Bulimo |
55 |
[GO] |
2022―Oct―31 |
Correction: comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection |
Rezvan Tavakoli, Pooneh Rahimi, Mojtaba Hamidi-Fard, Sana Eybpoosh, Delaram Doroud, Iraj Ahmadi, et al. (+3) Enayat Anvari, Mohammadreza Aghasadeghi, Abolfazl Fateh |
56 |
[GO] |
2022―Oct―24 |
Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting |
Walid F. Elkhatib, Shereen S. Abdelkareem, Wafaa S. Khalaf, Mona I. Shahin, Dounia Elfadil, Alaa Alhazmi, et al. (+2) Ahmed I. El-Batal, Gharieb S. El-Sayyad |
57 |
[GO] |
2022―Oct―18 |
SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing |
Steinar Mannsverk, Julia Bergholm, Navaneethan Palanisamy, Patrik Ellström, René Kaden, Johan Lindh, Johan Lennerstrand |
58 |
[GO] |
2022―Oct―03 |
Comparing the expression levels of tripartite motif containing 28 in mild and severe COVID-19 infection |
Rezvan Tavakoli, Pooneh Rahimi, Mojtaba Hamidi-Fard, Sana Eaybpoush, Delaram Doroud, Iraj Ahmadi, et al. (+3) Enayat Anvari, Mohammadreza Aghasadeghi, Abolfazl Fateh |
59 |
[GO] |
2022―Sep―22 |
Spectroscopic methods for COVID-19 detection and early diagnosis |
Alaa Bedair, Kamal Okasha, Fotouh R. Mansour |
60 |
[GO] |
2022―Sep―13 |
SARS-CoV-2 omicron variant clearance delayed in breakthrough cases with elevated fasting blood glucose |
Xiujun Zhang, Guocan Si, Huifen Lu, Wei Zhang, Shuqin Zheng, Zeyu Huang, et al. (+3) Longgen Liu, Yuan Xue, Guojun Zheng |
61 |
[GO] |
2022―Sep―10 |
Acquired agitation in acute respiratory distress syndrome with COVID-19 compared to influenza patients: a propensity score matching observational study |
Adel Maamar, Clémence Liard, Willelm Doucet, Florian Reizine, Benoit Painvin, Flora Delamaire, et al. (+6) Valentin Coirier, Quentin Quelven, Pauline Guillot, Mathieu Lesouhaitier, Jean Marc Tadié, Arnaud Gacouin |
62 |
[GO] |
2022―Sep―08 |
SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era |
Haifa Khemiri, Kaouther Ayouni, Henda Triki, Sondes Haddad-Boubaker |
63 |
[GO] |
2022―Sep―01 |
Performance evaluation of antigen detection rapid diagnostic test (Ag-RDT) for COVID-19 diagnosis in a primary healthcare center during the Shanghai COVID-19 quarantine period |
Lan Dong, Wen-Fang Li, Ying Jiang |
64 |
[GO] |
2022―Aug―23 |
High-density lipoproteins may play a crucial role in COVID-19 |
Minu Nain, Apoorv Gupta, Sumit Malhotra, Amit Sharma |
65 |
[GO] |
2022―Aug―08 |
Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis |
Mohammad-Mehdi Mehrabi Nejad, Parnian Shobeiri, Hojat Dehghanbanadaki, Mohammadreza Tabary, Armin Aryannejad, Abdolkarim Haji Ghadery, et al. (+4) Mahya Shabani, Fatemeh Moosaie, SeyedAhmad SeyedAlinaghi, Nima Rezaei |
66 |
[GO] |
2022―Jul―26 |
COVID-19 in Iran: clinical presentations and outcomes in three different surges of COVID-19 infection |
Azar Hadadi, Marzieh Pirzadeh, Sina Kazemian, Haleh Ashraf, Mehdi Ebrahimi, Shahrokh Karbalai Saleh, Mohammad Talebpour |
67 |
[GO] |
2022―Jun―27 |
A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge |
Jung-Eun Park, Ji-Hee Kim, Jae-Yeon Park, Sung-Hoon Jun, Hyun-Jin Shin |
68 |
[GO] |
2022―Jun―25 |
Direct mechanisms of SARS-CoV-2-induced cardiomyocyte damage: an update |
Yicheng Yang, Zhiyao Wei, Changming Xiong, Haiyan Qian |
69 |
[GO] |
2022―Jun―16 |
Tracking the molecular evolution and transmission patterns of SARS-CoV-2 lineage B.1.466.2 in Indonesia based on genomic surveillance data |
Mingjian Zhu, Qianli Zeng, Bryanna Infinita Laviashna Saputro, Sien Ping Chew, Ian Chew, Holie Frendy, et al. (+2) Joanna Weihui Tan, Lanjuan Li |
70 |
[GO] |
2022―Jun―13 |
Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients |
Arman Shafiee, Mohammad Mobin Teymouri Athar, Omid Kohandel Gargari, Kyana Jafarabady, Sepehr Siahvoshi, Sayed-Hamidreza Mozhgani |
71 |
[GO] |
2022―Jun―08 |
Herpesvirus and neurological manifestations in patients with severe coronavirus disease |
Vanessa Cristine de Souza Carneiro, Soniza Vieira Alves-Leon, Dmitry José de Santana Sarmento, Wagner Luis da Costa Nunes Pimentel Coelho, Otacilio da Cruz Moreira, Andreza Lemos Salvio, et al. (+6) Carlos Henrique Ferreira Ramos, Carlos Henrique Ferreira Ramos Filho, Carla Augusta Barreto Marques, João Paulo da Costa Gonçalves, Luciane Almeida Amado Leon, Vanessa Salete de Paula |
72 |
[GO] |
2022―Jun―05 |
Adverse effects of COVID-19 vaccines and measures to prevent them |
Kenji Yamamoto |
73 |
[GO] |
2022―May―28 |
Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron |
Bing Zhou, Lin Cheng, Shuo Song, Huimin Guo, Senlin Shen, Haiyan Wang, et al. (+4) Xiangyang Ge, Lei Liu, Bin Ju, Zheng Zhang |
74 |
[GO] |
2022―May―26 |
COVID-19 infection: an overview on cytokine storm and related interventions |
Soheila Montazersaheb, Seyed Mahdi Hosseiniyan Khatibi, Mohammad Saeid Hejazi, Vahideh Tarhriz, Afsaneh Farjami, Faramarz Ghasemian Sorbeni, et al. (+2) Raheleh Farahzadi, Tohid Ghasemnejad |
75 |
[GO] |
2022―May―26 |
First description of a multisystemic and lethal SARS-CoV-2 variant of concern P.1 (Gamma) infection in a FeLV-positive cat |
Rodrigo Lima Carneiro, Jéssica Pires Farias, Josilene Ramos Pinheiro, Jackson Farias, André Carloto Vielmo, Alexander Birbrair, et al. (+7) Aline Belmok, Fernando Lucas Melo, Bergmann Morais Ribeiro, Gepoliano Chaves, Paloma Oliveira Vidal, Wilson Barros Luiz, Jaime Henrique Amorim |
76 |
[GO] |
2022―May―21 |
Effect of herbal compounds on coronavirus; a systematic review and meta-analysis |
Mina Mobini Kesheh, Sara Shavandi, Niloofar Haeri Moghaddam, Moazzameh Ramezani, Fatemeh Ramezani |
77 |
[GO] |
2022―May―20 |
Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice |
Lianlian Bian, Yu Bai, Fan Gao, Mingchen Liu, Qian He, Xing Wu, et al. (+3) Qunying Mao, Miao Xu, Zhenglun Liang |
78 |
[GO] |
2022―May―15 |
NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study |
Justin T. Reese, Ben Coleman, Lauren Chan, Hannah Blau, Tiffany J. Callahan, Luca Cappelletti, et al. (+17) Tommaso Fontana, Katie R. Bradwell, Nomi L. Harris, Elena Casiraghi, Giorgio Valentini, Guy Karlebach, Rachel Deer, Julie A. McMurry, Melissa A. Haendel, Christopher G. Chute, Emily Pfaff, Richard Moffitt, Heidi Spratt, Jasvinder A. Singh, Christopher J. Mungall, Andrew E. Williams, Peter N. Robinson |
79 |
[GO] |
2022―May―15 |
Interaction of HnRNP F with the guanine-rich segments in viral antigenomic RNA enhances porcine reproductive and respiratory syndrome virus-2 replication |
Aiguo Zhang, Yanting Sun, Huiyuan Jing, Jie Liu, Erzhen Duan, Wenting Ke, et al. (+7) Ran Tao, Yang Li, Jinhe Wang, Sufang Cao, Pandeng Zhao, Haihua Wang, Yan Zhang |
80 |
[GO] |
2022―May―13 |
Plasma Torquetenovirus (TTV) microRNAs and severity of COVID-19 |
Maria Alfreda Stincarelli, Andreina Baj, Bernardo Guidotti, Pietro Giorgio Spezia, Federica Novazzi, Ersilia Lucenteforte, et al. (+4) Silvia Tillati, Daniele Focosi, Fabrizio Maggi, Simone Giannecchini |
81 |
[GO] |
2022―May―02 |
A fast extraction-free isothermal LAMP assay for detection of SARS-CoV-2 with potential use in resource-limited settings |
Kathleen Gärtner, Harry Meleke, Mercy Kamdolozi, David Chaima, Lyson Samikwa, Mary Paynter, et al. (+7) Maggie Nyirenda Nyang’Wa, Elaine Cloutman-Green, Eleni Nastouli, Nigel Klein, Tonney Nyirenda, Chisomo Msefula, Dagmar G. Alber |
82 |
[GO] |
2022―Apr―26 |
Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models |
Lena Mautner, Mona Hoyos, Alexandra Dangel, Carola Berger, Anja Ehrhardt, Armin Baiker |
83 |
[GO] |
2022―Apr―11 |
Establishment and evaluation of a quadruple quantitative real-time PCR assay for simultaneous detection of human coronavirus subtypes |
Mengchuan Zhao, Yi Xu, Dijun Zhang, Guixia Li, Huixia Gao, Xianping Zeng, et al. (+4) Yanqing Tie, Yong Wu, Erhei Dai, Zhishan Feng |
84 |
[GO] |
2022―Apr―11 |
Whole-genome sequencing and genetic characteristics of representative porcine reproductive and respiratory syndrome virus (PRRSV) isolates in Korea |
Seung-Chai Kim, Sung-Hyun Moon, Chang-Gi Jeong, Gyeong-Seo Park, Ji-Young Park, Hye-Young Jeoung, et al. (+6) Go-Eun Shin, Mi-Kyeong Ko, Seoung-Hee Kim, Kyoung-Ki Lee, Ho-Seong Cho, Won-Il Kim |
85 |
[GO] |
2022―Mar―29 |
Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19 |
Pengfei Pan, Xinxin Du, Qilong Zhou, Yong Cui, Xiaochun Deng, Chao Liu, et al. (+4) Zongjun Hu, Jianguo Chen, Xiangyou Yu, Weihua Shi |
86 |
[GO] |
2022―Mar―28 |
SARS-CoV2 RT-PCR assays: In vitro comparison of 4 WHO approved protocols on clinical specimens and its implications for real laboratory practice through variant emergence |
Mariem Gdoura, Imen Abouda, Mehdi Mrad, Imen Ben Dhifallah, Zeineb Belaiba, Wasfi Fares, et al. (+11) Anissa Chouikha, Maroua Khedhiri, Kaouther Layouni, Henda Touzi, Amel Sadraoui, Walid Hammemi, Zina Meddeb, Nahed Hogga, Sihem Ben Fadhel, Sondes Haddad-Boubaker, Henda Triki |
87 |
[GO] |
2022―Mar―19 |
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity |
Wenjing Gu, Hui Gan, Yu Ma, Lina Xu, Zhangkai J. Cheng, Bizhou Li, et al. (+5) Xinxing Zhang, Wujun Jiang, Jinlv Sun, Baoqing Sun, Chuangli Hao |
88 |
[GO] |
2022―Mar―19 |
SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease |
Nahid Alimoradi, Moein Sharqi, Dena Firouzabadi, Mohammad Moein Sadeghi, Mohammad Iman Moezzi, Negar Firouzabadi |
89 |
[GO] |
2022―Mar―19 |
Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections |
Ji Luo, Alexandra Brakel, Andor Krizsan, Tobias Ludwig, Marina Mötzing, Daniela Volke, et al. (+10) Nicole Lakowa, Thomas Grünewald, Claudia Lehmann, Johannes Wolf, Stephan Borte, Sanja Milkovska-Stamenova, Jörg Gabert, Felix Fingas, Markus Scholz, Ralf Hoffmann |
90 |
[GO] |
2022―Mar―15 |
COVID-19 epidemic in New York City: development of an age group-specific mathematical model to predict the outcome of various vaccination strategies |
Miaolei Li, Jian Zu, Yue Zhang, Le Ma, Mingwang Shen, Zongfang Li, Fanpu Ji |
91 |
[GO] |
2022―Mar―04 |
Bacterial and fungal co-infections with SARS-CoV-2 in solid organ recipients: a retrospective study |
Mojtaba Shafiekhani, Zahra Shekari, Arash Boorboor, Zahra Zare, Sara Arabsheybani, Nazanin Azadeh |
92 |
[GO] |
2022―Feb―10 |
A UV-LED module that is highly effective at inactivating human coronaviruses and HIV-1 |
Arvin T. Persaud, Jonathan Burnie, Laxshaginee Thaya, Liann DSouza, Steven Martin, Christina Guzzo |
93 |
[GO] |
2022―Feb―03 |
Comparison of six antibody assays and two combination assays for COVID-19 |
Masaki Yamamoto, Kazuyuki Okazaki, Yoko Kitai, Koh Shinohara, Satomi Yukawa, Taro Noguchi, et al. (+4) Michio Tanaka, Yasufumi Matsumura, Yukiko Nishiyama, Miki Nagao |
94 |
[GO] |
2022―Feb―03 |
Correction to: The interactions of ZDHHC5/GOLGA7 with SARS-CoV-2 spike (S) protein and their effects on S protein’s subcellular localization, palmitoylation and pseudovirus entry |
Xiao-Tao Zeng, Xiao-Xi Yu, Wei Cheng |
95 |
[GO] |
2022―Jan―06 |
Mental health status of COVID-19 survivors: a cross sectional study |
Munam Raza Jafri, Anna Zaheer, Sahar Fatima, Taiba Saleem, Atif Sohail |
96 |
[GO] |
2022―Jan―06 |
Management skin manifestation of multisystem inflammatory syndrome associated with SARS-CoV-2 |
Yeter Eylul Bayram, Dilek Yildiz-Sevgi, Ayse Yavuz, Merve Cancetin, Mehmet Yavuz Gurler |
97 |
[GO] |
2022―Jan―04 |
Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in mice |
Shuo Song, Bing Zhou, Lin Cheng, Weilong Liu, Qing Fan, Xiangyang Ge, et al. (+4) Hua Peng, Yang-Xin Fu, Bin Ju, Zheng Zhang |
98 |
[GO] |
2021―Dec―27 |
The interactions of ZDHHC5/GOLGA7 with SARS-CoV-2 spike (S) protein and their effects on S protein’s subcellular localization, palmitoylation and pseudovirus entry |
Xiao-Tao Zeng, Xiao-Ti Yu, Wei Cheng |
99 |
[GO] |
2021―Dec―20 |
Simulation study reveals factors that affect the predominance of SARS-CoV-2 novel variant |
Yuki Furuse |
100 |
[GO] |
2021―Dec―07 |
COVID-19 in renal transplant recipients and general population: a comparative study of clinical, laboratory, and radiological features, severity, and outcome |
Ali Monfared, Leila Akhondzadeh, Mahsa Mousazadeh, Atefeh Jafari, Masoud Khosravi, Mohammadkazem Lebadi, et al. (+7) Pegah Aghajanzadeh, Yalda Haghdar-Saheli, Ali Movassaghi, Elham Ramezanzadeh, Farzaneh Shobeirian, Ehsan Kazemnezhad, Samaneh Esmaeili |
101 |
[GO] |
2021―Dec―07 |
Expression of plasma IFN signaling-related miRNAs during acute SARS-CoV-2 infection and its association with RBD-IgG antibody response |
Jing Wu, Xingxiang Liu, Jianguo Shao, Yuanyuan Zhang, Renfei Lu, Hong Xue, et al. (+6) Yunfang Xu, Lijuan Wang, Hui Zhou, Lugang Yu, Ming Yue, Chen Dong |
102 |
[GO] |
2021―Dec―06 |
Correction to: Predictors of the chest CT score in COVID-19 patients: a cross-sectional study |
Niloofar Ayoobi Yazdi, Abdolkarim Haji Ghadery, SeyedAhmad SeyedAlinaghi, Fatemeh Jafari, Sirous Jafari, Malihe Hasannezad, et al. (+9) Hamid Emadi Koochak, Mohammadreza Salehi, Seyed Ali Dehghan Manshadi, Mohsen Meidani, Mahboubeh Hajiabdolbaghi, Zahra Ahmadinejad, Hossein Khalili, Mohammad-Mehdi Mehrabi Nejad, Ladan Abbasian |
103 |
[GO] |
2021―Nov―22 |
Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand? |
Mojtaba Shafiekhani, Farbod Shahabinezhad, Tahmoores Niknam, Seyed Ahmad Tara, Elham Haem, Parviz Mardani, et al. (+10) Zahra Zare, Sedigheh Jafarian, Khatereh Mirzad Jahromi, Sara Arabsheybani, Yalda Sadat Moeini, Jalile Alavi, Seyed Soroush Jalali, Maryam Salimi, Reza Shahriarirad, Seyed Ali Malekhosseini |
104 |
[GO] |
2021―Nov―18 |
Predictors of the chest CT score in COVID-19 patients: a cross-sectional study |
Niloofar Ayoobi Yazdi, Abdolkarim Haji Ghadery, Seyed Ahmad Seyedalinaghi, Fatemeh Jafari, Sirous Jafari, Malihe Hasannezad, et al. (+9) Hamid Emadi Koochak, Mohammadreza Salehi, Seyed Ali Dehghan Manshadi, Mohsen Meidani, Mahboubeh Hajiabdolbaghi, Zahra Ahmadinejad, Hossein Khalili, Mohammad-Mehdi Mehrabinejad, Ladan Abbasian |
105 |
[GO] |
2021―Nov―17 |
Re-emergence of Gamma-like-II and emergence of Gamma-S:E661D SARS-CoV-2 lineages in the south of Brazil after the 2021 outbreak |
Mauro M. Oliveira, Michelle O. Schemberger, Andreia A. Suzukawa, Irina N. Riediger, Maria do Carmo Debur, Guilherme Becker, et al. (+19) Paola Cristina Resende, Tiago Gräf, Eduardo Balsanelli, Valter Antônio de Baura, Emanuel M. de Souza, Fábio O. Pedrosa, Lysangela R. Alves, Lucas Blanes, Sheila Cristina Nardelli, Alessandra M. Aguiar, Letusa Albrecht, Dalila Zanette, Andréa R. Ávila, Luis Gustavo Morello, Fabricio K. Marchini, Hellen G. dos Santos, Fabio Passetti, Bruno Dallagiovanna, Helisson Faoro |
106 |
[GO] |
2021―Nov―14 |
The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients |
Pooneh Rahimi, Rahil Tarharoudi, Alireza Rahimpour, Jalal Mosayebi Amroabadi, Iraj Ahmadi, Enayat Anvari, et al. (+3) Seyed Davar Siadat, Mohammadreza Aghasadeghi, Abolfazl Fateh |
107 |
[GO] |
2021―Oct―29 |
Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection |
Hind Hamzeh-Cognasse, Alexandre Mansour, Florian Reizine, Patrick Mismetti, Isabelle Gouin-Thibault, Fabrice Cognasse |
108 |
[GO] |
2021―Oct―18 |
Porcine reproductive and respiratory syndrome virus genetic variability a management and diagnostic dilemma |
Jessica Risser, Matthew Ackerman, Robert Evelsizer, Stephen Wu, Byungjoon Kwon, James Mark Hammer |
109 |
[GO] |
2021―Oct―13 |
Investigation of astrovirus, coronavirus and paramyxovirus co-infections in bats in the western Indian Ocean |
Axel O. G. Hoarau, Steven M. Goodman, Dana Al Halabi, Beza Ramasindrazana, Erwan Lagadec, Gildas Le Minter, et al. (+6) Marie Köster, Andréa Dos Santos, M. Corrie Schoeman, Eduardo S. Gudo, Patrick Mavingui, Camille Lebarbenchon |
110 |
[GO] |
2021―Oct―10 |
Comparison of 11 respiratory pathogens among hospitalized children before and during the COVID-19 epidemic in Shenzhen, China |
Li Li, Heping Wang, Ailiang Liu, Rongjun Wang, Tingting Zhi, Yuejie Zheng, et al. (+3) Yanming Bao, Yunsheng Chen, Wenjian Wang |
111 |
[GO] |
2021―Sep―08 |
In vitro efficacy of Artemisia extracts against SARS-CoV-2 |
Chuanxiong Nie, Jakob Trimpert, Sooyeon Moon, Rainer Haag, Kerry Gilmore, Benedikt B. Kaufer, Peter H. Seeberger |
112 |
[GO] |
2021―Sep―05 |
Case report: hepatitis in a child infected with SARS-CoV-2 presenting toll-like receptor 7 Gln11Leu single nucleotide polymorphism |
Natália Lima Pessoa, Aline Almeida Bentes, Andrea Lucchesi de Carvalho, Thaís Bárbara de Souza Silva, Pedro Augusto Alves, Erik Vinicius de Sousa Reis, et al. (+3) Tayse Andrade Rodrigues, Erna Geessien Kroon, Marco Antônio Campos |
113 |
[GO] |
2021―Aug―30 |
Optimization and validation of RT-LAMP assay for diagnosis of SARS-CoV2 including the globally dominant Delta variant |
Vijay Lakshmi Jamwal, Natish Kumar, Rahul Bhat, Piyush Singh Jamwal, Kaurab Singh, Sandeep Dogra, et al. (+7) Abhishek Kulkarni, Bhaskar Bhadra, Manish R. Shukla, Saurabh Saran, Santanu Dasgupta, Ram A. Vishwakarma, Sumit G. Gandhi |
114 |
[GO] |
2021―Aug―14 |
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021 |
Alessia Lai, Annalisa Bergna, Stefano Menzo, Gianguglielmo Zehender, Sara Caucci, Valeria Ghisetti, et al. (+33) Francesca Rizzo, Fabrizio Maggi, Francesco Cerutti, Giorgio Giurato, Alessandro Weisz, Chiara Turchi, Bianca Bruzzone, Francesca Ceccherini Silberstein, Nicola Clementi, Annapaola Callegaro, Fabio Sagradi, Daniela Francisci, Emmanuele Venanzi Rullo, Ilaria Vicenti, Massimo Clementi, Massimo Galli, Claudia Balotta, Maria Gori, Patrizia Bagnarelli, Andreina Baj, Federica Novazzi, Andrea Orsi, Patrizia Caligiuri, Simona Boccotti, Maria Concetta Bellocchi, Loredana Sarmati, Massimo Andreoni, Nicasio Mancini, Elena Criscuolo, Rosa Gallitelli, Sophie Testa, Filippo Dragoni, Maurizio Zazzi |
115 |
[GO] |
2021―Aug―13 |
Evolutionary trajectory of SARS-CoV-2 and emerging variants |
Jalen Singh, Pranav Pandit, Andrew G. McArthur, Arinjay Banerjee, Karen Mossman |
116 |
[GO] |
2021―Aug―03 |
Impact of COVID-19 pandemic on the prevalence of respiratory viruses in children with lower respiratory tract infections in China |
Pengcheng Liu, Menghua Xu, Lingfeng Cao, Liyun Su, Lijuan Lu, Niuniu Dong, et al. (+3) Ran Jia, Xunhua Zhu, Jin Xu |
117 |
[GO] |
2021―Jul―27 |
Association of dyslipidemia with the severity and mortality of coronavirus disease 2019 (COVID-19): a meta-analysis |
Yanli Liu, Yilong Pan, Yuyao Yin, Wenhao Chen, Xiaodong Li |
118 |
[GO] |
2021―Jul―23 |
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics |
Lennox Chitsike, Penelope Duerksen-Hughes |
119 |
[GO] |
2021―Jul―18 |
SARS-CoV-2: preliminary study of infected human nasopharyngeal tissue by high resolution microscopy |
Brian Mondeja, Odalys Valdes, Sonia Resik, Ananayla Vizcaino, Emilio Acosta, Adelmo Montalván, et al. (+11) Amira Paez, Mayra Mune, Roberto Rodríguez, Juan Valdés, Guelsys Gonzalez, Daisy Sanchez, Viviana Falcón, Yorexis González, Vivian Kourí, Angelina Díaz, María Guzmán |
120 |
[GO] |
2021―Jul―14 |
Clinical and virological course of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center cohort study |
Rui Huang, Li Zhu, Leyang Xue, Xuebing Yan, Jian Wang, Songping Huang, et al. (+27) Biao Zhang, Tianmin Xu, Fang Ji, Chunyang Li, Fang Ming, Yun Zhao, Yang Li, Juan Cheng, Yinling Wang, Huaping Shao, Shuqin Hong, Kang Chen, Xiang-an Zhao, Dawen Sang, Lei Zou, Haiyan Zhao, Xinying Guan, Xiaobing Chen, Biyun Xu, Juan Xia, Yuxin Chen, Xiaomin Yan, Jie Wei, Jiacheng Liu, Longgen Liu, Chuanwu Zhu, Chao Wu |
121 |
[GO] |
2021―Jul―08 |
Antiviral drugs arbidol and interferon alpha-1b contribute to reducing the severity of COVID-19 patients: a retrospective cohort study |
Peng Yin, Juan Meng, Jincheng Chen, Junxiao Gao, Dongqi Wang, Shuyan Liu, et al. (+6) Qinglong Guo, Muchun Zhu, Gengwei Zhang, Yingxia Liu, Ye Li, Guoliang Zhang |
122 |
[GO] |
2021―Jul―03 |
Transmission frequency of COVID-19 through pre-symptomatic and asymptomatic patients in AJK: a report of 201 cases |
Majid Mahmood, Noor-ul-ain Ilyas, Muhammad Faraz Khan, Muhammad Naseem Hasrat, Nicholas Richwagen |
123 |
[GO] |
2021―Jul―01 |
Persistence of SARS-CoV-2 RNA in the nasopharyngeal, blood, urine, and stool samples of patients with COVID-19: a hospital-based longitudinal study |
Farahnaz Joukar, Tofigh Yaghubi Kalurazi, Mahmoud Khoshsorour, Sonbol Taramian, Lida Mahfoozi, Heydar Ali Balou, et al. (+9) Alireza Jafarinezhad, Aydin Pourkazemi, Ezat Hesni, Mehrnaz Asgharnezhad, Mohammad Shenagari, Issa Jahanzad, Mohammadreza Naghipour, Saman Maroufizadeh, Fariborz Mansour-Ghanaei |
124 |
[GO] |
2021―Jun―28 |
Impact of joint management of a COVID-19 mother and her newborn on the virus transmission: a case report |
Maria Chiara De Nardo, Anna Rita Bellomo, Francesca Perfetti, Francesco Antonino Battaglia, Miriam Lichtner, Riccardo Lubrano |
125 |
[GO] |
2021―Jun―14 |
Influenza co-infection associated with severity and mortality in COVID-19 patients |
Bandar Alosaimi, Asif Naeem, Maaweya E. Hamed, Haitham S. Alkadi, Thamer Alanazi, Sanaa Saad Al Rehily, et al. (+2) Abdullah Z. Almutairi, Adnan Zafar |
126 |
[GO] |
2021―Jun―12 |
Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study |
Shi-Wei Yin, Zheng Zhou, Jun-Ling Wang, Yun-Feng Deng, Hui Jing, Yi Qiu |
127 |
[GO] |
2021―Jun―09 |
Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives |
Kexin Yan, Daniel J. Rawle, Thuy T. Le, Andreas Suhrbier |
128 |
[GO] |
2021―Jun―09 |
Liver injury in COVID-19: clinical features and treatment management |
Dongdong Yu, Qingru Du, Shengguang Yan, Xu-Guang Guo, Yehao He, Guodong Zhu, et al. (+2) Kewei Zhao, Shi Ouyang |
129 |
[GO] |
2021―Jun―07 |
A comprehensive review on clinical and mechanistic pathophysiological aspects of COVID-19 Malady: How far have we come? |
Baila Shakaib, Tanzeel Zohra, Aamer Ikram, Muhammad Bin Shakaib, Amna Ali, Adnan Bashir, et al. (+3) Muhammad Salman, Mumtaz Ali khan, Jamil Ansari |
130 |
[GO] |
2021―Jun―04 |
Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction |
Jiajia Wang, Xinjing Yang, Yongsheng Li, Jian-an Huang, Junhong Jiang, Nan Su |
131 |
[GO] |
2021―Jun―04 |
Lymphocyte-monocyte-neutrophil index: a predictor of severity of coronavirus disease 2019 patients produced by sparse principal component analysis |
Yingjie Qi, Jian-an Jia, Huiming Li, Nagen Wan, Shuqin Zhang, Xiaoling Ma |
132 |
[GO] |
2021―Jun―02 |
Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2 |
Janine Michel, Markus Neumann, Eva Krause, Thomas Rinner, Therese Muzeniek, Marica Grossegesse, et al. (+11) Georg Hille, Franziska Schwarz, Andreas Puyskens, Sophie Förster, Barbara Biere, Daniel Bourquain, Cristina Domingo, Annika Brinkmann, Lars Schaade, Livia Schrick, Andreas Nitsche |
133 |
[GO] |
2021―Jun―02 |
SARS-CoV-2 in hospital indoor environments is predominantly non-infectious |
Janina Krambrich, Dario Akaberi, Jiaxin Ling, Tove Hoffman, Lennart Svensson, Marie Hagbom, Åke Lundkvist |
134 |
[GO] |
2021―May―25 |
Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case-control study |
Anıl Ucan, Pamir Cerci, Serdar Efe, Hakan Akgun, Ahmet Ozmen, Aysel Yagmuroglu, et al. (+2) Muzaffer Bilgin, Deniz Avci |
135 |
[GO] |
2021―May―21 |
Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study |
Xiao Hou, Li Tian, Lei Zhou, Xinhua Jia, Li Kong, Yitao Xue, et al. (+4) Hao Hao, Xianqing Meng, Feihu Zhang, Xiaobin Dong |
136 |
[GO] |
2021―May―17 |
Comparison of SARS-CoV-2 indirect and direct RT-qPCR detection methods |
Joel D. Pearson, Daniel Trcka, Suying Lu, Sharon J. Hyduk, Mark Jen, Marie-Ming Aynaud, et al. (+11) J. Javier Hernández, Philippos Peidis, Miriam Barrios-Rodiles, Kin Chan, Jim Woodgett, Tony Mazzulli, Liliana Attisano, Laurence Pelletier, Myron I. Cybulsky, Jeffrey L. Wrana, Rod Bremner |
137 |
[GO] |
2021―May―04 |
Excellent option for mass testing during the SARS-CoV-2 pandemic: painless self-collection and direct RT-qPCR |
Eva Kriegova, Regina Fillerova, Milan Raska, Jirina Manakova, Martin Dihel, Ondrej Janca, et al. (+4) Pavel Sauer, Martina Klimkova, Petra Strakova, Petr Kvapil |
138 |
[GO] |
2021―May―03 |
Broad respiratory testing to identify SARS-CoV-2 viral co-circulation and inform diagnostic stewardship in the COVID-19 pandemic |
Natalie C. Marshall, Ruwandi M. Kariyawasam, Nathan Zelyas, Jamil N. Kanji, Mathew A. Diggle |
139 |
[GO] |
2021―Apr―30 |
Etiology and clinical characteristics of SARS-CoV-2 and other human coronaviruses among children in Zhejiang Province, China 2017-2019 |
Yanjun Zhang, Lingxuan Su, Yin Chen, Sicong Yu, Dan Zhang, Haiyan Mao, Lei Fang |
140 |
[GO] |
2021―Apr―30 |
Sequence and phylogentic analysis of MERS-CoV in Saudi Arabia, 2012-2019 |
Mohamed A. Farrag, Haitham M. Amer, Rauf Bhat, Fahad N. Almajhdi |
141 |
[GO] |
2021―Apr―28 |
Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes |
Lin Cheng, Shuo Song, Bing Zhou, Xiangyang Ge, Jiazhen Yu, Mingxia Zhang, et al. (+2) Bin Ju, Zheng Zhang |
142 |
[GO] |
2021―Apr―20 |
Correction to: An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value |
Sissy Therese Sonnleitner, Julian Dorighi, Bianca Jansen, Carmen Schönegger, Sarah Gietl, Stephan Koblmüller, et al. (+3) Christian Sturmbauer, Wilfried Posch, Gernot Walder |
143 |
[GO] |
2021―Apr―07 |
An in vitro model for assessment of SARS-CoV-2 infectivity by defining the correlation between virus isolation and quantitative PCR value: isolation success of SARS-CoV-2 from oropharyngeal swabs correlates negatively with Cq value |
Sonnleitner Sissy Therese, Dorighi Julian, Jansen Bianca, Schönegger Carmen, Gietl Sarah, Koblmüller Stephan, et al. (+3) Sturmbauer Christian, Posch Wilfried, Walder Gernot |
144 |
[GO] |
2021―Mar―31 |
Scores based on neutrophil percentage and lactate dehydrogenase with or without oxygen saturation predict hospital mortality risk in severe COVID-19 patients |
Xiude Fan, Bin Zhu, Masoud Nouri-Vaskeh, Chunguo Jiang, Xiaokai Feng, Kyle Poulsen, et al. (+9) Behzad Baradaran, Jiansong Fang, Erfan Ahmadi Ade, Akbar Sharifi, Zhigang Zhao, Qunying Han, Yong Zhang, Liming Zhang, Zhengwen Liu |
145 |
[GO] |
2021―Mar―29 |
Precision therapeutic targets for COVID-19 |
Zachary A. Krumm, Grace M. Lloyd, Connor P. Francis, Lith H. Nasif, Duane A. Mitchell, Todd E. Golde, et al. (+2) Benoit I. Giasson, Yuxing Xia |
146 |
[GO] |
2021―Mar―20 |
How home anterior self-collected nasal swab simplifies SARS-CoV-2 testing: new surveillance horizons in public health and beyond |
Silvia Ricci, Lorenzo Lodi, Francesco Citera, Francesco Nieddu, Maria Moriondo, Valentina Guarnieri, et al. (+5) Mattia Giovannini, Giuseppe Indolfi, Massimo Resti, Alberto Zanobini, Chiara Azzari |
147 |
[GO] |
2021―Mar―17 |
Evaluation of patients with COVID-19 diagnosis for chronic diseases |
Murat Altuntas, Habip Yilmaz, Abdullah Emre Guner |
148 |
[GO] |
2021―Mar―17 |
COVID-19 infection among healthcare workers: a cross-sectional study in southwest Iran |
Golnar Sabetian, Mohsen Moghadami, Leila Hashemizadeh Fard Haghighi, Reza Shahriarirad, Mohammad Javad Fallahi, Naeimehossadat Asmarian, Yalda Sadat Moeini |
149 |
[GO] |
2021―Mar―11 |
Assessment of dengue and COVID-19 antibody rapid diagnostic tests cross-reactivity in Indonesia |
Marsha S. Santoso, Sri Masyeni, Sotianingsih Haryanto, Benediktus Yohan, Martin L. Hibberd, R. Tedjo Sasmono |
150 |
[GO] |
2021―Mar―10 |
Optimal preparation of SARS-CoV-2 viral transport medium for culture |
Julie McAuley, Claire Fraser, Elena Paraskeva, Elizabeth Trajcevska, Michelle Sait, Nancy Wang, et al. (+3) Eric Bert, Damian Purcell, Richard Strugnell |
151 |
[GO] |
2021―Mar―09 |
Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients |
Jira Chansaenroj, Ritthideach Yorsaeng, Nawarat Posuwan, Jiratchaya Puenpa, Natthinee Sudhinaraset, Chintana Chirathaworn, Yong Poovorawan |
152 |
[GO] |
2021―Feb―27 |
Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice |
Chao Shang, Xinyu Zhuang, He Zhang, Yiquan Li, Yilong Zhu, Jing Lu, et al. (+6) Chenchen Ge, Jianan Cong, Tingyu Li, Mingyao Tian, Ningyi Jin, Xiao Li |
153 |
[GO] |
2021―Feb―20 |
Correction to: Poor sensitivity of "AccuPower SARS-CoV-2 real time RT-PCR kit (Bioneer, South Korea)" |
Byron Freire-Paspuel, Miguel Angel Garcia-Bereguiain |
154 |
[GO] |
2021―Feb―13 |
Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy |
Umar Saeed, Sara Rizwan Uppal, Zahra Zahid Piracha, Azhar Rasheed, Zubair Aftab, Hafsah Zaheer, Rizwan Uppal |
155 |
[GO] |
2021―Feb―11 |
Pneumonia scoring systems for severe COVID-19: which one is better |
PengFei Cheng, Hao Wu, JunZhe Yang, XiaoYang Song, MengDa Xu, BiXi Li, et al. (+4) JunJun Zhang, MingZhe Qin, Cheng Zhou, Xiang Zhou |
156 |
[GO] |
2021―Jan―12 |
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein |
Hideki Tani, Miyuki Kimura, Long Tan, Yoshihiro Yoshida, Tatsuhiko Ozawa, Hiroyuki Kishi, et al. (+11) Shuetsu Fukushi, Masayuki Saijo, Kaori Sano, Tadaki Suzuki, Hitoshi Kawasuji, Akitoshi Ueno, Yuki Miyajima, Yasutaka Fukui, Ippei Sakamaki, Yoshihiro Yamamoto, Yoshitomo Morinaga |
157 |
[GO] |
2021―Jan―09 |
False negative rate of COVID-19 PCR testing: a discordant testing analysis |
Jamil N. Kanji, Nathan Zelyas, Clayton MacDonald, Kanti Pabbaraju, Muhammad Naeem Khan, Abhaya Prasad, et al. (+4) Jia Hu, Mathew Diggle, Byron M. Berenger, Graham Tipples |
158 |
[GO] |
2021―Jan―07 |
Higher expression of monocyte chemotactic protein 1 in mild COVID-19 patients might be correlated with inhibition of Type I IFN signaling |
Xueyan Xi, Yang Guo, Min Zhu, Yuhui Wei, Gang Li, Boyu Du, Yunfu Wang |
159 |
[GO] |
2021―Jan―04 |
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions |
Yue Zheng, Erin T. Larragoite, Elizabeth S. C. P. Williams, Juan Lama, Isabel Cisneros, Julio C. Delgado, et al. (+7) Patricia Slev, Jenna Rychert, Emily A. Innis, Mayte Coiras, Matthew T. Rondina, Adam M. Spivak, Vicente Planelles |
160 |
[GO] |
2020―Dec―28 |
Analysis and validation of a highly sensitive one-step nested quantitative real-time polymerase chain reaction assay for specific detection of severe acute respiratory syndrome coronavirus 2 |
Yang Zhang, Chunyang Dai, Huiyan Wang, Yong Gao, Tuantuan Li, Yan Fang, et al. (+5) Zuojun Shen, Lichang Chen, Zhaowu Chen, Xuejun Ma, Ming Li |
161 |
[GO] |
2020―Dec―18 |
Efficient SARS-CoV-2 detection in unextracted oro-nasopharyngeal specimens by rRT-PCR with the Seegene Allplex™ 2019-nCoV assay |
Wesley Freppel, Natacha Merindol, Fabien Rallu, Marco Bergevin |
162 |
[GO] |
2020―Dec―10 |
Comparative analysis of clinical features of SARS-CoV-2 and adenovirus infection among children |
Kuanrong Li, Ling Li, Xianfeng Wang, Hui Li, Jun Chen, Lei Liu, et al. (+6) Jianbo Shao, Yi Xu, Liya He, Sitang Gong, Huimin Xia, Huiying Liang |
163 |
[GO] |
2020―Nov―26 |
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease |
Mohamed Mahdi, János András Mótyán, Zsófia Ilona Szojka, Mária Golda, Márió Miczi, József Tőzsér |
164 |
[GO] |
2020―Nov―23 |
Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2 |
Wai Sing Chan, Chun Hang Au, Ho Yin Lam, Candy Ling Na Wang, Dona Ngar-Yin Ho, Yuk Man Lam, et al. (+6) Daniel Ka Wing Chu, Leo Lit Man Poon, Tsun Leung Chan, Jonpaul Sze-Tsing Zee, Edmond Shiu Kwan Ma, Bone Siu Fai Tang |
165 |
[GO] |
2020―Nov―14 |
Poor sensitivity of "AccuPower SARS-CoV-2 real time RT-PCR kit (Bioneer, South Korea)" |
Byron Freire-Paspuel, Miguel Angel Garcia-Bereguiain |
166 |
[GO] |
2020―Nov―13 |
Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand |
Chutikarn Chaimayo, Bualan Kaewnaphan, Nattaya Tanlieng, Niracha Athipanyasilp, Rujipas Sirijatuphat, Methee Chayakulkeeree, et al. (+9) Nasikarn Angkasekwinai, Ruengpung Sutthent, Nattawut Puangpunngam, Theerawoot Tharmviboonsri, Orawan Pongraweewan, Suebwong Chuthapisith, Yongyut Sirivatanauksorn, Wannee Kantakamalakul, Navin Horthongkham |
167 |
[GO] |
2020―Nov―09 |
Author Correction: In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2 |
Johanna Signer, Hulda R. Jonsdottir, Werner C. Albrich, Marc Strasser, Roland Züst, Sarah Ryter, et al. (+6) Rahel Ackermann-Gäumann, Nicole Lenz, Denise Siegrist, Andreas Suter, Roland Schoop, Olivier B. Engler |
168 |
[GO] |
2020―Oct―29 |
Prediction and evolution of B cell epitopes of surface protein in SARS-CoV-2 |
Jerome Rumdon Lon, Yunmeng Bai, Bingxu Zhong, Fuqiang Cai, Hongli Du |
169 |
[GO] |
2020―Oct―23 |
Clinical features and efficacy of antiviral drug, Arbidol in 220 nonemergency COVID-19 patients from East-West-Lake Shelter Hospital in Wuhan: a retrospective case series |
Wei Gao, Si Chen, Kun Wang, Rongzhang Chen, Qian Guo, Jingjing Lu, et al. (+8) Xiaodong Wu, Yanan He, Qiaoyun Yan, Shengyun Wang, Feilong Wang, Li Jin, Jing Hua, Qiang Li |
170 |
[GO] |
2020―Oct―21 |
The chest CT features of coronavirus disease 2019 (COVID-19) in China: a meta-analysis of 19 retrospective studies |
Haitao Yang, Yuzhu Lan, Xiujuan Yao, Sheng Lin, Baosong Xie |
171 |
[GO] |
2020―Oct―21 |
Rapid point-of-care detection of SARS-CoV-2 using reverse transcription loop-mediated isothermal amplification (RT-LAMP) |
Lena Mautner, Christin-Kirsty Baillie, Heike Marie Herold, Wolfram Volkwein, Patrick Guertler, Ute Eberle, et al. (+8) Nikolaus Ackermann, Andreas Sing, Melanie Pavlovic, Ottmar Goerlich, Ulrich Busch, Lars Wassill, Ingrid Huber, Armin Baiker |
172 |
[GO] |
2020―Oct―15 |
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents |
Sumanth Khadke, Nayla Ahmed, Nausheen Ahmed, Ryan Ratts, Shine Raju, Molly Gallogly, et al. (+2) Marcos de Lima, Muhammad Rizwan Sohail |
173 |
[GO] |
2020―Oct―07 |
Estimation of the basic reproduction number (R0) for the novel coronavirus disease in Sri Lanka |
Samath Dharmaratne, Supun Sudaraka, Ishanya Abeyagunawardena, Kasun Manchanayake, Mahen Kothalawala, Wasantha Gunathunga |
174 |
[GO] |
2020―Oct―07 |
The effect of temperature on persistence of SARS-CoV-2 on common surfaces |
Shane Riddell, Sarah Goldie, Andrew Hill, Debbie Eagles, Trevor W. Drew |
175 |
[GO] |
2020―Oct―02 |
COVID-19 pandemic: current knowledge about the role of pets and other animals in disease transmission |
Mulugeta Kiros, Henok Andualem, Teklehaimanot Kiros, Wasihun Hailemichael, Sisay Getu, Alene Geteneh, et al. (+2) Derbie Alemu, Woldaregay Erku Abegaz |
176 |
[GO] |
2020―Sep―24 |
Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis |
Dhan Bahadur Shrestha, Pravash Budhathoki, Sitaram Khadka, Prajwol Bikram Shah, Nisheem Pokharel, Prama Rashmi |
177 |
[GO] |
2020―Sep―14 |
Characterization of codon usage pattern in SARS-CoV-2 |
Wei Hou |
178 |
[GO] |
2020―Sep―10 |
In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2 |
Johanna Signer, Hulda R. Jonsdottir, Werner C. Albrich, Marc Strasser, Roland Züst, Sarah Ryter, et al. (+6) Rahel Ackermann-Gäumann, Nicole Lenz, Denise Siegrist, Andreas Suter, Roland Schoop, Olivier B. Engler |
179 |
[GO] |
2020―Aug―27 |
Characterization of accessory genes in coronavirus genomes |
Christian Jean Michel, Claudine Mayer, Olivier Poch, Julie Dawn Thompson |
180 |
[GO] |
2020―Aug―25 |
A novel two-step, direct-to-PCR method for virus detection off swabs using human coronavirus 229E |
Zachary P. Morehouse, Caleb M. Proctor, Gabriella L. Ryan, Rodney J. Nash |
181 |
[GO] |
2020―Aug―18 |
Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase |
Robert W. Cross, Krystle N. Agans, Abhishek N. Prasad, Viktoriya Borisevich, Courtney Woolsey, Daniel J. Deer, et al. (+4) Natalie S. Dobias, Joan B. Geisbert, Karla A. Fenton, Thomas W. Geisbert |
182 |
[GO] |
2020―Jul―29 |
SARS-CoV-2: characteristics and current advances in research |
Yicheng Yang, Zhiqiang Xiao, Kaiyan Ye, Xiaoen He, Bo Sun, Zhiran Qin, et al. (+5) Jianghai Yu, Jinxiu Yao, Qinghua Wu, Zhang Bao, Wei Zhao |
183 |
[GO] |
2020―Jul―29 |
Small molecules block the interaction between porcine reproductive and respiratory syndrome virus and CD163 receptor and the infection of pig cells |
Chang Huang, Denzil Bernard, Jiaqi Zhu, Radha Charan Dash, Alexander Chu, Alec Knupp, et al. (+4) Anna Hakey, M. Kyle Hadden, Antonio Garmendia, Young Tang |
184 |
[GO] |
2020―Jul―08 |
The newly emerged COVID-19 disease: a systemic review |
Endeshaw Chekol Abebe, Tadesse Asmamaw Dejenie, Mestet Yibeltal Shiferaw, Tabarak Malik |
185 |
[GO] |
2020―Jul―08 |
Relapsing viral keratoconjunctivitis in COVID-19: a case report |
Dongyu Guo, Jianhua Xia, Yang Wang, Xuhong Zhang, Ye Shen, Jian-Ping Tong |
186 |
[GO] |
2020―Jun―30 |
Evaluation of SARS-CoV-2 viral RNA in fecal samples |
Alvaro Mesoraca, Katia Margiotti, Antonella Viola, Antonella Cima, Davide Sparacino, Claudio Giorlandino |
187 |
[GO] |
2020―Jun―19 |
Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report |
Tian-min Xu, Bin Lin, Cong Chen, Long-gen Liu, Yuan Xue |
188 |
[GO] |
2020―Jun―17 |
Challenge infection model for MERS-CoV based on naturally infected camels |
Naif Khalaf Alharbi, Osman H. Ibrahim, Ali Alhafufi, Samy Kasem, Ali Aldowerij, Raed Albrahim, et al. (+8) Ali Abu-obaidah, Ali Alkarar, Faisal Altaib Bayoumi, Ali Mohammed Almansour, Musaad Aldubaib, Hail M. Al-Abdely, Hanan H. Balkhy, Ibrahim Qasim |
189 |
[GO] |
2020―Jun―03 |
Three kinds of treatment with Homoharringtonine, Hydroxychloroquine or shRNA and their combination against coronavirus PEDV in vitro |
Cui-Cui Li, Xiao-Jia Wang |